About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: February 2020
Emerging Pathogens, Communications
In June 1981 I graduated from law school. One month after that an article appeared in the New York Times with the headline “Rare Cancer Seen in 41 Homosexuals” on page A20. These two events would end up pretty much … Continue reading
Posted in Current Affairs
Comments Off on Emerging Pathogens, Communications
The Side Effects of a Coronavirus Epidemic for Pharma
There are a lot of important facts on the FDA’s Web Page set up to provide information about the novel coronoavirus (2019-nCOV) outbreak, now dubbed COVID-19. But there are three sobering statements that stand out: There are no FDA-approved diagnostics … Continue reading
Posted in Current Affairs
Tagged #coronavirus #COVID-19
Comments Off on The Side Effects of a Coronavirus Epidemic for Pharma
FDA Takes A Number of Actions to Enhance the Market for Biosimilars – A Process Not an Event
There is a policy interest in driving the biosimilar market. Among other reasons, increasing the number of generic drugs and biosimilars on the market addresses another policy priority – having an impact on the high cost of medicine. The approval … Continue reading
Posted in Biologics, FDA Policy
Comments Off on FDA Takes A Number of Actions to Enhance the Market for Biosimilars – A Process Not an Event